These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population. Wu D, Jiang H, Gu Q, Zhang D, Li Z. Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894 [Abstract] [Full Text] [Related]
3. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis. Liu B, Shen T. Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436 [Abstract] [Full Text] [Related]
4. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women. Malisic EJ, Krivokuca AM, Boljevic IZ, Jankovic RN. Cancer Biomark; 2015 Jan; 15(5):685-91. PubMed ID: 26406958 [Abstract] [Full Text] [Related]
5. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies. Wu K, Su D, Lin K, Luo J, Au WW. Asian Pac J Cancer Prev; 2011 Jan; 12(9):2237-43. PubMed ID: 22296363 [Abstract] [Full Text] [Related]
6. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis. Liu BM, Liu TM, You BS, You HY, Yang J, Li L, He YC. Genet Mol Res; 2012 Nov 12; 11(4):3852-60. PubMed ID: 23212324 [Abstract] [Full Text] [Related]
8. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk. Dong LM, Zhang XY, Teng H, Li MS, Wang P. Genet Mol Res; 2014 Nov 28; 13(4):9976-85. PubMed ID: 25501209 [Abstract] [Full Text] [Related]
9. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis. Wei X, Chen D, Lv T. Mol Biol Rep; 2013 Jan 28; 40(1):567-72. PubMed ID: 23096083 [Abstract] [Full Text] [Related]
10. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis. Peng M, Zhou X, Ding X, Wei L, Zhao Y, Zhu T, Shi X, Qin D. Rheumatol Int; 2017 Mar 28; 37(3):435-444. PubMed ID: 27812739 [Abstract] [Full Text] [Related]
11. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies. Liu C, Yin Q, Jiao G, Zhou X, Ying M, Gao W, Hu J, Wei L, Wang N, Wang Y. DNA Cell Biol; 2014 Jun 28; 33(6):378-87. PubMed ID: 24694255 [Abstract] [Full Text] [Related]
12. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls. Huang Y, Xie D, Tang N, Wang J, Zeng X, Zhao P, He L. Tumour Biol; 2014 Jan 28; 35(1):799-808. PubMed ID: 23990457 [Abstract] [Full Text] [Related]
20. Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects. Niwa Y, Matsuo K, Ito H, Hirose K, Tajima K, Nakanishi T, Nawa A, Kuzuya K, Tamakoshi A, Hamajima N. Gynecol Oncol; 2005 Oct 28; 99(1):43-9. PubMed ID: 15990162 [Abstract] [Full Text] [Related] Page: [Next] [New Search]